Meeting
2011 ASCO Annual Meeting
Symptom experiences and nonadherent medication-taking behaviors of breast cancer patients taking adjuvant hormone therapy.
Authors
R. A. Shelby
Duke University Medical Center, Durham, NC
R. A. Shelby , F. J. Keefe , S. N. Red , K. L. Blackwell , J. M. Peppercorn , P. K. Marcom , G. G. Kimmick
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Breast Cancer - HER2/ER
Track
Breast Cancer
Sub Track
ER+
Citation
J Clin Oncol 29: 2011 (suppl; abstr 524)
Abstract #
524
Poster Bd #
13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Influence of ovarian function supression on quality of life in breast cancer survivors during adjuvant endocrine therapy.
First Author: Natalija Dedic Plavetic
Poster
2021 ASCO Annual Meeting
Associations between preexisting nociplastic pain and early discontinuation of aromatase inhibitor therapy in breast cancer.
First Author: Elizabeth Joyce
Poster
2011 ASCO Annual Meeting
Adjuvant hormone therapy use in early-stage breast cancer patients insured by the New York State Medicaid program.
First Author: R. L. Yung
Poster
2023 ASCO Annual Meeting
lidERA Breast Cancer (BC): Phase III adjuvant study of giredestrant vs. physician’s choice of endocrine therapy (PCET) in patients (pts) with estrogen receptor-positive, HER2-negative early BC (ER+, HER2– eBC).
First Author: Charles Geyer